Sex steroid and growth factor profile of a meningioma associated with pregnancy

Canadian Journal of Neurological Sciences

Volumn 32, Issue 1, 2005, Pages 122-127

  Smith, Justin S ^a   Quiñones Hinojosa, Alfredo ^a   Harmon Smith, Miranda ^a   Bollen, Andrew W ^b   McDermott, Michael W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GENE PRODUCT; GROWTH FACTOR; HUMAN PLACENTA LACTOGEN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROGESTERONE RECEPTOR; SEX HORMONE;

ADULT; ARTICLE; CANCER GRADING; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; SEIZURE; TUMOR REGRESSION; TUMOR VOLUME;

EID: 14944362700     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100017017     Document Type: Article

References (39)

1. Longstreth WT, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD. Epidemiology of intracranial meningioma. Cancer 1993; 72: 639-648.
2. Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998; 73: 936-942.
3. Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958; 21: 89-91.
4. Black PML. Hormone, radiosurgery and virtual reality; new aspects of meningioma management. Can J Neurol Sci 1997; 24: 302-306.
5. Benzel EC, Gelder FB. Correlation between sex hormone binding and peritumoural edema in intracranial meingiomas. Neurosurgery 1988; 23: 169-174.
6. DeGrood RM, Beemer WH, Fenner DE, Compton AA. A large meningioma presenting as a neurologic emergency in late pregnancy. Obstet Gynecol 1987; 69: 439-440.
7. Kempers RD, Miller RH. Management of pregnancy associated with brain tumours. Am J Obstet Gynecol 1963; 87: 858-864.
8. Schlehofer B, Blettner M, Wahrendorf J. Association between brain tumours and menopausal status. J Natl Cancer Inst 1992; 84: 1346-1349.
9. Helseth A, Mork SJ, Glattre E. Neoplasms of the central nervous system in Norway. V, meningioma and cancer of other sites. An analysis of the occurrence of multiple primary neoplasms in meningioma patients in Norway from 1955 through 1986. APMIS 1989; 97: 738-744.
10. Schoenberg BS, Christine BW, Whisant JP. Nervous system neoplasms and the primary malignancies of other sites. The unique association between meningiomas and breast cancer. Neurology 1975; 28: 705-712.
11. Brandis A, Mirazi S, Tatagiba M, et al. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 1993; 33: 212-217.
12. Carroll RS, Zhang J, Dashner K, Black PML. Progesterone and glucocorticoid activation in meningiomas. Neurosurgery 1995; 37: 92-97.
13. Fewings PE, Battersby RD, Timperley WR. Long-term follow up of progesterone receptor status in benign meningioma: a prognostic indicator of recurrence? J Neurosurg 2000; 92: 401-405.
14. Hsu DW, Efird JT, Hedley-Whyte ET. Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997; 86: 113-120.
15. Perry A, Cai DX, Scheithauer BW, et al. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J Neuropathol Exp Neurol 2000; 59: 872-879.
16. Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K. Steroid receptor proteins in human meningiomas. Cancer 1982; 49: 633-636.
17. Verheijen FM, Sprong M, Jacobs GH, et al. Progesterone receptor isoform expression in human meningiomas. Eur J Cancer 2001; 37: 1488-1495.
18. Roelvink NCA, Kamphorst W, van Alphen HAM, Rao BR. Pregnancy-related primary brain and spinal tumours. Arch Neurol 1987; 44: 209-215.
19. Philippen J, Foncin JF, Grob R, et al. Cerebral edema associated with meningiomas: Possible role of a secretory-excretory phenomenon. Neurosurgery 1984; 14: 295-301.
20. Isla A, Alvarez F, Gonzalez A, et al. Brain tumour and pregnancy. Obstet Gynecol 1997; 89: 19-23.
21. Giannini A, Bricchi M. Posterior fossa surgery in the sitting position in a pregnant patient with cerebellopontine angle meningioma. Br J Anaesth 1999; 82: 941-944.
22. Goldberg M, Rappaport ZH. Neurosurgical, obstetric and endocrine aspects of meningioma during pregnancy. Isr J Med Sci 1987; 23: 825-828.
23. Ismail K, Coakham HB, Walters FJ. Intracranial meningioma with progesterone positive receptors presenting in late pregnancy. Eur J Anaesthesiol 1998; 15: 106-109.
24. Old SE, Burnet NG, Macfarlane R, O'Donovan DG, Langmack K. Post-partum retreatment with iridium-192 wire brachytherapy for meninaioma recurring in pregnancy. Clin Oncol 2001; 13: 114-116.
25. Pliskow S, Herbst SJ, Saiontz HA, Cove H, Ackerman RT. Intracranial meningioma with positive progesterone receptors: a case report. J Reprod Med 1995; 40: 154-156.
26. Saitoh Y, Oku Y, Izumoto S, Go J. Rapid growth of a meningioma during pregnancy: relationship with estrogen and progesterone receptors. Neurol Med Chir (Tokyo) 1989; 29: 440-443.
27. Sanson M, Cornu P. Biology of meningiomas. Acta Neurochir (Wien) 2000; 142: 493-505.
28. Carroll RS, Glowacka D, Dashner K, Black PM. Progesterone receptor expression in menineiomas. Cancer Res 1993; 53: 1312-1326.
29. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth-factor. Endocr Rev 1987; 8: 95-114.
30. Gross JL, Morrison RS, Eidsvoog K, et al. Basic fibroblast growth-factor - a potential autocrine regulator of human glioma cell-growth. J Neurosci Res 1990; 27: 689-696.
31. Lamszus K, Lengler U, Dchmidt NO, et al. Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000; 46: 938-948.
32. Takahashi JA, Suzui H, Yasuda Y, et al. Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. Biochem Biophys Res Commun 1991; 177: 1-7.
33. Takahashi JA, Mori H. Fukumoto M, et al. Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular or basic fibroblast growth factor mRNA and peptide in tumour tissue. Proc Natl Acad Sci USA 1990; 87: 5710.
34. Black PML, Carroll R, Glowacka D, Riley K, Dashner K. Platelet-derived growth factor expression and stimulation in human meningiomas. J Neurosurg 1994; 81: 388-393.
35. Maxwell M, Galanopoulos T, Hedley-Whyte ET, Black PML, Antoniades HN. Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and protein products. Int J Cancer 1990; 46: 16-21.
36. Yang SY, Xu GM. Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. J Clin Neurosci 2000; 8: 49-53.
37. Boyle-Walsh E, Shenkin A, White MC, Fraser WD, Effect of glycoprotein and protein hormones on human meningioma cell proliferation in vitro. J Endocrinol 1995; 145: 155-161.
38. Carroll RS, Black PML, Zhang J, et al. Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 1997; 87: 315-323.
39. Jones NR, Rossi ML. Gregoriou M, Hughes JT. Epidermal growth factor receptor expression in 72 meningiomas. Cancer 1990; 66: 152-155.